The Claim
Myocardial perfusion scintigraphy with 99mTc-Sestamibi detects functional cardiac abnormalities in hyperthyroid patients without known coronary artery disease.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
A nuclear imaging test using 99mTc-Sestamibi identifies abnormal heart function in people with hyperthyroidism who do not have known coronary artery disease.
See the scientific wording
Myocardial perfusion scintigraphy with 99mTc-Sestamibi can detect functional cardiac abnormalities in hyperthyroid patients without known coronary artery disease, suggesting it may have utility in cardiovascular risk stratification for this population.
Too much thyroid hormone makes the heart work harder and faster, which uses up more oxygen. The small blood vessels in the heart cannot deliver enough extra blood to meet this demand, especially when the heart is stressed. This shortage of blood flow shows up as dark spots on a heart scan using a special dye.
What the research says
1 studyThis study found that even hyperthyroid patients with no heart disease often have reduced blood flow to the heart during stress, which can be seen with a special heart scan called 99mTc-Sestamibi MPS. This means the scan could help doctors spot who’s at higher risk for heart problems before symptoms appear.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.